🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

✨Thrilled to be attending AACR-KCA 2024 in Seoul to present the long-term FU & biomarker results from our cetux/nivo trial in R/M HNSCC ✨ Moffitt Research Moffitt Cancer Center 🔥Beyond grateful for the travel grant award AACR 🙏

At #SITC24, Mihaela Druta, MD (Mihaela Druta) discusses translational analyses that reveal afami-cel's anti-tumor mechanisms in synovial sarcoma. #MoffittSITC24 ⏰: 11/9 4:39 p.m. CT 📍: Grand Ballroom B Learn more ➡️ bit.ly/3NTJQGX Society for Immunotherapy of Cancer

At #ASH24, Fnu Amisha, MD (Amisha Gupta) presents predictive markers for outcomes after disease progression post BCMA-directed CAR T-cell therapy in patients with relapsed or refractory multiple myeloma. Learn more: bit.ly/3CUTJlf ASH #MoffittASH24

Join Fatima Tuz Zahra, MBBS (@TuzZFatima) at #ASH24 as she discusses real world outcomes of oral azacitidine maintenance therapy for acute myeloid leukemia. Read more: bit.ly/3ZDipYq ASH #MoffittASH24

Join Moazzam Shahzad, MD at #ASH24 as he presents a systematic review and meta-analysis on the risks of JAK inhibitors, aiming to enhance understanding and support safer therapeutic use. Read more: bit.ly/3BgfawJ ASH #MoffittASH24

At #ASH24, join Shrinjaya B Thapa, MD as she presents a retrospective analysis of clinical characteristics and outcomes of patients with MYD88 positive Waldenström macroglobuliemia. Read more: bit.ly/4fXUKrF ASH #MoffittASH24

At #ASH24, Fnu Amisha, MD (Amisha Gupta) discussed predictive markers for outcomes after disease progression post BCMA-directed CAR T-cell therapy in patients with relapsed or refractory multiple myeloma (RRMM). ➡️The prognosis of RRMM who develop progressive disease

At #ASH24, Fatima Tuz Zahra presents real world outcomes of oral azacitidine maintenance therapy for acute myeloid leukemia. Read more: ash.confex.com/ash/2024/webpr… @ASH_hematoloy #MoffittASH24

At #ASH24, Ziad Abuhelwa, MD (@zabuhelwa) discusses a retrospective analysis of the outcomes of a large cohort of MDS patients to compare outcomes between IDH1-MT and wild-type. Read more: bit.ly/41n9c7P ASH #ASH24

🎉 Our Moffitt/USF Hem/Onc Fellowship Team celebrated the season with a fantastic wellness holiday party! 🌟 Had an amazing time wrapping up 2024! Wishing everyone Happy Holidays! 🎄✨ #Hematology #Oncology #Fellowship Moffitt Cancer Center USF Health

Excited to share our first 2025 publication addressing a critical gap by exploring allo-HCT outcomes in geriatric patients, a historically underrepresented group in clinical trials due to toxicity and mortality concerns. Transplantation and Cellular Therapy Journal Moffitt Cancer Center sciencedirect.com/science/articl…

Excited to share our publication on ctDNA in resected BTC JCO Precision Oncology! 🔗 https:ascopubs.org/doi/10.1200/PO… 👉ctDNA is prognostic for relapse (HR 20-26) 👉Outperforms CA19-9 for relapse correlation 👉Potentially Detects recurrence earlier (avg lead time 3.7 mo) #BTC #ctDNA #MRD

This week, we highlighted research by james Yu, Ruth He, MD, PhD, Mahmoud Ouf, MD, Jason W Denbo, Adham Jurdi, Richard D Kim, and others published in JCO Precision Oncology. Learn more: bit.ly/4262xzh. Georgetown Lombardi Moffitt Cancer Center Natera Oncology

Detecting Early Recurrence With Circulating Tumor DNA in Stage I-III Biliary Tract Cancer After Curative Resection: brnw.ch/21wQ1TG Authored by james Yu brnw.ch/21wQ1TH #gicsm

Honored to be selected for the prestigious Robert A. Good Honor Society (#RGHS), awarded to no more than 1% of all trainees. Grateful to my amazing Hem/Onc program, colleagues, and mentors! University of South Florida Moffitt Cancer Center

🎉 Our Moffitt/USF Hem/Onc Fellowship Team held a Wellness Event! 🌟 Great way to recharge as we wrap up the Academic Year—just 2.5 months to go! #FellowshipLife #Wellness #HemOnc #Hematology #Oncology #Fellowship Moffitt Cancer Center USF Health

Honored to share our Journal of the @NCCN review on biomarker-driven approaches for Metastatic Gastric Cancer doi.org/10.6004/jnccn.… Grateful for the amazing guidance and mentorship of Rutika Mehta #GastricCancer #OncologyResearch

Sharing our recent publication in Cancers MDPI aiming to identify favorable factors contributing to survival benefits in resected pancreatic adenocarcinoma after NACT james Yu MDPI Moffitt Cancer Center #Oncology #pancreaticcancer

At #ASCO25, Richard Kim, MD, presents new data from the HERIZON-BTC-01 trial, comparing survival outcomes for zanidatamab-hrii vs chemotherapy in previously treated HER2-positive (IHC3+) biliary tract cancer. #MoffittASCO25 Read more: meetings.asco.org/2025-asco-annu… ASCO

Join Karun Neupane, MD, (Karun Neupane, MD), tomorrow at #ASCO25 as he shares research highlighting barriers for major career awards for international medical graduates. Read more: meetings.asco.org/2025-asco-annu… #MoffittASCO25 ASCO